The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms

163Citations
Citations of this article
104Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The somatically acquired V600E mutation of the BRAF gene has been recently described as a molecular marker of hairy cell leukemia (HCL). We developed an allele-specific PCR for this mutation and studied 62 patients with HCL, 1 with HCL variant, 91 with splenic marginal zone lymphoma, 29 with Waldenström macroglobulinemia, and 57 with B-cell chronic lymphoproliferative disorders. The BRAF V600E mutation was detected in all HCL cases and in only 2 of the remaining 178 patients. These 2 subjects had B-cell chronic lymphoproliferative disorders that did not fulfill the diagnostic criteria for HCL. Despite the positive PCR finding, the mutation could not be detected by Sanger sequencing in these 2 cases, suggesting that it was associated with a small subclone. We conclude that the BRAF V600E mutation is present in all patients with HCL and that, in combination with clinical and morphologic features, represents a reliable molecular marker for this condition. © 2012 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Arcaini, L., Zibellini, S., Boveri, E., Riboni, R., Rattotti, S., Varettoni, M., … Cazzola, M. (2012). The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood, 119(1), 188–191. https://doi.org/10.1182/blood-2011-08-368209

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free